Generics - USA, Antibiotics and Infectious diseases

Filter

Popular Filters

FTC approves final order on Akorn divestment in bid for VersaPharm

FTC approves final order on Akorn divestment in bid for VersaPharm

21-09-2014

Following a public comment period, the US Federal Trade Commission has approved a final order settling…

AkornAntibiotics and Infectious diseasesGenericsLegalMergers & AcquisitionsRifampinUSAVersaPharm

FTC puts conditions on Akorn’s proposed acquisition of VersaPharm

FTC puts conditions on Akorn’s proposed acquisition of VersaPharm

05-08-2014

The US Federal Trade Commission revealed yesterday that US generics drugmaker Akorn has agreed to sell…

AkornAntibiotics and Infectious diseasesClinical researchGeneric injectable tuberculosisGenericsMergers & AcquisitionsRegulationRifampinUSAVersaPharm

ANI Pharma acquires Vancocin assets from Shire

ANI Pharma acquires Vancocin assets from Shire

02-08-2014

US generic drugmaker ANI Pharmaceuticals says it has acquired the US rights for the antibiotic Vancocin…

ANI PharmaceuticalsAntibiotics and Infectious diseasesEli Lilly and CompanyGenericsGlycopeptide antibioticsIrelandMergers & AcquisitionsNew DrugShireUSAVancocinVancomycin HCl

Drug pricing power led by hepatitis C, diabetes and cancer

Drug pricing power led by hepatitis C, diabetes and cancer

13-06-2014

Hepatitis C, diabetes and cancer are sustaining high pricing power through innovation according to Morningstar's…

AbbVieAntibiotics and Infectious diseasesBiogen IdecCopaxoneDiabetesGenericsGilead SciencesMerck & CoOncologyPharmaceuticalPricingTecfideraTeva Pharmaceutical IndustriesUSA

Parexel

Parexel

Back to top